skip to main content
Ngôn ngữ:
Giới hạn tìm kiếm: Giới hạn tìm kiếm: Dạng tài nguyên Hiển thị kết quả với: Hiển thị kết quả với: Dạng tìm kiếm Chỉ mục

Kết quả 1 - 10 của 571  trong Tất cả tài nguyên

Sắp xếp theo: Sắp xếp theo: Thích hợpOr hit Enter to replace sort method
Kết quả 1 2 3 4 5 next page
Lọc theo: Nhan đề tạp chí: Annals Of The Rheumatic Diseases xóa Chủ đề: Humans xóa
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Annals of the rheumatic diseases, 2019-06, Vol.78 (6), p.736-745 [Tạp chí có phản biện]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215089 ;PMID: 30926722

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
2
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Annals of the rheumatic diseases, 2015-09, Vol.74 (9), p.1706-1713 [Tạp chí có phản biện]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2013-205171 ;PMID: 24834926 ;CODEN: ARDIAO

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
3
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

Annals of the rheumatic diseases, 2012-09, Vol.71 (9), p.1524-1529 [Tạp chí có phản biện]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2011-200726 ;PMID: 22425941 ;CODEN: ARDIAO

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
4
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

Annals of the rheumatic diseases, 2018-02, Vol.77 (2), p.212-220 [Tạp chí có phản biện]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0 ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-211682 ;PMID: 29066464

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
5
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.48-54 [Tạp chí có phản biện]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-211735 ;PMID: 28877868

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
6
A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality
A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality

Annals of the rheumatic diseases, 2017-10, Vol.76 (10), p.1700-1706 [Tạp chí có phản biện]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2017 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-211138 ;PMID: 28611082

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
7
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Annals of the rheumatic diseases, 2016-02, Vol.75 (2), p.382-389 [Tạp chí có phản biện]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2014-206008 ;PMID: 25480887 ;CODEN: ARDIAO

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
8
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response

Annals of the rheumatic diseases, 2019-11, Vol.78 (11), p.1454-1462 [Tạp chí có phản biện]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215764 ;PMID: 31362993

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
9
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.98-103 [Tạp chí có phản biện]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-211836 ;PMID: 28970215

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
10
Genetics of rheumatoid arthritis: 2018 status
Genetics of rheumatoid arthritis: 2018 status
Material Type:
Bài báo 		Thêm vào Góc nghiên cứu

Genetics of rheumatoid arthritis: 2018 status

Annals of the rheumatic diseases, 2019-04, Vol.78 (4), p.446-453 [Tạp chí có phản biện]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2018-213678 ;PMID: 30530827

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi

Kết quả 1 - 10 của 571  trong Tất cả tài nguyên

Sắp xếp theo: Sắp xếp theo: Thích hợpOr hit Enter to replace sort method
Kết quả 1 2 3 4 5 next page

Chủ đề của tôi

  1. Thiết lập

Refine Search Results

Mở rộng kết quả tìm kiếm

  1.   

Chỉ hiển thị

  1. Tài liệu số/Tài liệu điện tử (569)

Lọc kết quả

Năm xuất bản 

Từ đến
Chọn
  1. Trước2001  (12)
  2. 2001 đến 2005  (99)
  3. 2006 đến 2010  (126)
  4. 2011 đến 2016  (176)
  5. Sau 2016  (159)
  6. Lựa chọn khác open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Đang tìm Cơ sở dữ liệu bên ngoài...